180 related articles for article (PubMed ID: 31089709)
1. The role of plasma microseminoprotein-beta in prostate cancer: an observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition.
Smith Byrne K; Appleby PN; Key TJ; Holmes MV; Fensom GK; Agudo A; Ardanaz E; Boeing H; Bueno-de-Mesquita HB; Chirlaque MD; Kaaks R; Larrañaga N; Palli D; Perez-Cornago A; Quirós JR; Ricceri F; Sánchez MJ; Tagliabue G; Tsilidis KK; Tumino R; Fortner RT; Ferrari P; ; Riboli E; Lilja H; Travis RC
Ann Oncol; 2019 Jun; 30(6):983-989. PubMed ID: 31089709
[TBL] [Abstract][Full Text] [Related]
2. Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations.
Haiman CA; Stram DO; Vickers AJ; Wilkens LR; Braun K; Valtonen-André C; Peltola M; Pettersson K; Waters KM; Marchand LL; Kolonel LN; Henderson BE; Lilja H
J Natl Cancer Inst; 2013 Feb; 105(3):237-43. PubMed ID: 23213189
[TBL] [Abstract][Full Text] [Related]
3. A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations.
Waters KM; Stram DO; Le Marchand L; Klein RJ; Valtonen-André C; Peltola MT; Kolonel LN; Henderson BE; Lilja H; Haiman CA
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2639-46. PubMed ID: 20736317
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms at the Microseminoprotein-beta locus associated with physiologic variation in beta-microseminoprotein and prostate-specific antigen levels.
Xu X; Valtonen-André C; Sävblom C; Halldén C; Lilja H; Klein RJ
Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):2035-42. PubMed ID: 20696662
[TBL] [Abstract][Full Text] [Related]
5. Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition.
Schmidt JA; Fensom GK; Rinaldi S; Scalbert A; Appleby PN; Achaintre D; Gicquiau A; Gunter MJ; Ferrari P; Kaaks R; Kühn T; Floegel A; Boeing H; Trichopoulou A; Lagiou P; Anifantis E; Agnoli C; Palli D; Trevisan M; Tumino R; Bueno-de-Mesquita HB; Agudo A; Larrañaga N; Redondo-Sánchez D; Barricarte A; Huerta JM; Quirós JR; Wareham N; Khaw KT; Perez-Cornago A; Johansson M; Cross AJ; Tsilidis KK; Riboli E; Key TJ; Travis RC
BMC Med; 2017 Jul; 15(1):122. PubMed ID: 28676103
[TBL] [Abstract][Full Text] [Related]
6. A Four-kallikrein Panel and β-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer.
Assel M; Sjöblom L; Murtola TJ; Talala K; Kujala P; Stenman UH; Taari K; Auvinen A; Vickers A; Visakorpi T; Tammela TL; Lilja H
Eur Urol Focus; 2019 Jul; 5(4):561-567. PubMed ID: 29137895
[TBL] [Abstract][Full Text] [Related]
7. Cysteine-rich secretory protein 3 and β-microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcome.
Hoogland AM; Dahlman A; Vissers KJ; Wolters T; Schröder FH; Roobol MJ; Bjartell AS; van Leenders GJ
BJU Int; 2011 Oct; 108(8):1356-62. PubMed ID: 21410630
[TBL] [Abstract][Full Text] [Related]
8. Prospective validation of microseminoprotein-β added to the 4Kscore in predicting high-grade prostate cancer in an international multicentre cohort.
Lonergan PE; Vertosick EA; Assel M; Sjoberg DD; Haese A; Graefen M; Boorjian SA; Klee GG; Cooperberg MR; Pettersson K; Routila E; Vickers AJ; Lilja H
BJU Int; 2021 Aug; 128(2):218-224. PubMed ID: 33306251
[TBL] [Abstract][Full Text] [Related]
9. Prospective and Mendelian randomization analyses on the association of circulating fatty acid binding protein 4 (FABP-4) and risk of colorectal cancer.
Nimptsch K; Aleksandrova K; Pham TT; Papadimitriou N; Janke J; Christakoudi S; Heath A; Olsen A; Tjønneland A; Schulze MB; Katzke V; Kaaks R; van Guelpen B; Harbs J; Palli D; Macciotta A; Pasanisi F; Yohar SMC; Guevara M; Amiano P; Grioni S; Jakszyn PG; Figueiredo JC; Samadder NJ; Li CI; Moreno V; Potter JD; Schoen RE; Um CY; Weiderpass E; Jenab M; Gunter MJ; Pischon T
BMC Med; 2023 Oct; 21(1):391. PubMed ID: 37833736
[TBL] [Abstract][Full Text] [Related]
10. Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses.
Seyed Khoei N; Jenab M; Murphy N; Banbury BL; Carreras-Torres R; Viallon V; Kühn T; Bueno-de-Mesquita B; Aleksandrova K; Cross AJ; Weiderpass E; Stepien M; Bulmer A; Tjønneland A; Boutron-Ruault MC; Severi G; Carbonnel F; Katzke V; Boeing H; Bergmann MM; Trichopoulou A; Karakatsani A; Martimianaki G; Palli D; Tagliabue G; Panico S; Tumino R; Sacerdote C; Skeie G; Merino S; Bonet C; Rodríguez-Barranco M; Gil L; Chirlaque MD; Ardanaz E; Myte R; Hultdin J; Perez-Cornago A; Aune D; Tsilidis KK; Albanes D; Baron JA; Berndt SI; Bézieau S; Brenner H; Campbell PT; Casey G; Chan AT; Chang-Claude J; Chanock SJ; Cotterchio M; Gallinger S; Gruber SB; Haile RW; Hampe J; Hoffmeister M; Hopper JL; Hsu L; Huyghe JR; Jenkins MA; Joshi AD; Kampman E; Larsson SC; Le Marchand L; Li CI; Li L; Lindblom A; Lindor NM; Martín V; Moreno V; Newcomb PA; Offit K; Ogino S; Parfrey PS; Pharoah PDP; Rennert G; Sakoda LC; Schafmayer C; Schmit SL; Schoen RE; Slattery ML; Thibodeau SN; Ulrich CM; van Duijnhoven FJB; Weigl K; Weinstein SJ; White E; Wolk A; Woods MO; Wu AH; Zhang X; Ferrari P; Anton G; Peters A; Peters U; Gunter MJ; Wagner KH; Freisling H
BMC Med; 2020 Sep; 18(1):229. PubMed ID: 32878631
[TBL] [Abstract][Full Text] [Related]
11. Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Travis RC; Crowe FL; Allen NE; Appleby PN; Roddam AW; Tjønneland A; Olsen A; Linseisen J; Kaaks R; Boeing H; Kröger J; Trichopoulou A; Dilis V; Trichopoulos D; Vineis P; Palli D; Tumino R; Sieri S; Bueno-de-Mesquita HB; van Duijnhoven FJ; Chirlaque MD; Barricarte A; Larrañaga N; González CA; Argüelles MV; Sánchez MJ; Stattin P; Hallmans G; Khaw KT; Bingham S; Rinaldi S; Slimani N; Jenab M; Riboli E; Key TJ
Am J Epidemiol; 2009 May; 169(10):1223-32. PubMed ID: 19359375
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. The association between circulating 25-hydroxyvitamin D metabolites and type 2 diabetes in European populations: A meta-analysis and Mendelian randomisation analysis.
Zheng JS; Luan J; Sofianopoulou E; Sharp SJ; Day FR; Imamura F; Gundersen TE; Lotta LA; Sluijs I; Stewart ID; Shah RL; van der Schouw YT; Wheeler E; Ardanaz E; Boeing H; Dorronsoro M; Dahm CC; Dimou N; El-Fatouhi D; Franks PW; Fagherazzi G; Grioni S; Huerta JM; Heath AK; Hansen L; Jenab M; Jakszyn P; Kaaks R; Kühn T; Khaw KT; Laouali N; Masala G; Nilsson PM; Overvad K; Olsen A; Panico S; Quirós JR; Rolandsson O; Rodríguez-Barranco M; Sacerdote C; Spijkerman AMW; Tong TYN; Tumino R; Tsilidis KK; Danesh J; Riboli E; Butterworth AS; Langenberg C; Forouhi NG; Wareham NJ
PLoS Med; 2020 Oct; 17(10):e1003394. PubMed ID: 33064751
[TBL] [Abstract][Full Text] [Related]
14. Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort.
Bonilla C; Lewis SJ; Martin RM; Donovan JL; Hamdy FC; Neal DE; Eeles R; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Pashayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Pandha H; Lathrop M; Davey Smith G;
BMC Med; 2016 Apr; 14():66. PubMed ID: 27044414
[TBL] [Abstract][Full Text] [Related]
15. Circulating phosphorus concentration and risk of prostate cancer: a Mendelian randomization study.
Lv L; Ye D; Chen J; Qian Y; Fu AN; Song J; Yang H; Liu B; Sun X; Du L; Mao Y
Am J Clin Nutr; 2022 Feb; 115(2):534-543. PubMed ID: 34617559
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses.
Cui H; Zhang W; Zhang L; Qu Y; Xu Z; Tan Z; Yan P; Tang M; Yang C; Wang Y; Chen L; Xiao C; Zou Y; Liu Y; Zhang L; Yang Y; Yao Y; Li J; Liu Z; Yang C; Jiang X; Zhang B
PLoS Med; 2024 Mar; 21(3):e1004362. PubMed ID: 38489391
[TBL] [Abstract][Full Text] [Related]
17. Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition.
Travis RC; Key TJ; Allen NE; Appleby PN; Roddam AW; Rinaldi S; Egevad L; Gann PH; Rohrmann S; Linseisen J; Pischon T; Boeing H; Johnsen NF; Tjønneland A; Overvad K; Kiemeney L; Bueno-de-Mesquita HB; Bingham S; Khaw KT; Tumino R; Sieri S; Vineis P; Palli D; Quirós JR; Ardanaz E; Chirlaque MD; Larrañaga N; Gonzalez C; Sanchez MJ; Trichopoulou A; Bikou C; Trichopoulos D; Stattin P; Jenab M; Ferrari P; Slimani N; Riboli E; Kaaks R
Int J Cancer; 2007 Sep; 121(6):1331-8. PubMed ID: 17514649
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in the ADIPOQ gene, adiponectin concentrations and risk of colorectal cancer: a Mendelian Randomization analysis using data from three large cohort studies.
Nimptsch K; Song M; Aleksandrova K; Katsoulis M; Freisling H; Jenab M; Gunter MJ; Tsilidis KK; Weiderpass E; Bueno-De-Mesquita HB; Chong DQ; Jensen MK; Wu C; Overvad K; Kühn T; Barrdahl M; Melander O; Jirström K; Peeters PH; Sieri S; Panico S; Cross AJ; Riboli E; Van Guelpen B; Myte R; Huerta JM; Rodriguez-Barranco M; Quirós JR; Dorronsoro M; Tjønneland A; Olsen A; Travis R; Boutron-Ruault MC; Carbonnel F; Severi G; Bonet C; Palli D; Janke J; Lee YA; Boeing H; Giovannucci EL; Ogino S; Fuchs CS; Rimm E; Wu K; Chan AT; Pischon T
Eur J Epidemiol; 2017 May; 32(5):419-430. PubMed ID: 28550647
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I concentration and risk of prostate cancer: results from the European Prospective Investigation into Cancer and Nutrition.
Price AJ; Allen NE; Appleby PN; Crowe FL; Travis RC; Tipper SJ; Overvad K; Grønbæk H; Tjønneland A; Johnsen NF; Rinaldi S; Kaaks R; Lukanova A; Boeing H; Aleksandrova K; Trichopoulou A; Trichopoulos D; Andarakis G; Palli D; Krogh V; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; Argüelles MV; Sánchez MJ; Chirlaque MD; Barricarte A; Larrañaga N; González CA; Stattin P; Johansson M; Khaw KT; Wareham N; Gunter M; Riboli E; Key T
Cancer Epidemiol Biomarkers Prev; 2012 Sep; 21(9):1531-41. PubMed ID: 22761305
[TBL] [Abstract][Full Text] [Related]
20. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition.
Allen NE; Key TJ; Appleby PN; Travis RC; Roddam AW; Rinaldi S; Egevad L; Rohrmann S; Linseisen J; Pischon T; Boeing H; Johnsen NF; Tjønneland A; Grønbaek H; Overvad K; Kiemeney L; Bueno-de-Mesquita HB; Bingham S; Khaw KT; Tumino R; Berrino F; Mattiello A; Sacerdote C; Palli D; Quirós JR; Ardanaz E; Navarro C; Larrañaga N; Gonzalez C; Sanchez MJ; Trichopoulou A; Travezea C; Trichopoulos D; Jenab M; Ferrari P; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1121-7. PubMed ID: 17548673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
